tiprankstipranks
Advertisement
Advertisement
Sutro Biopharma management to meet with Citizens
PremiumThe FlySutro Biopharma management to meet with Citizens
19d ago
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
Premium
The Fly
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
25d ago
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
Premium
The Fly
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
25d ago
Wells upgrades Sutro to Overweight ahead of STRO-004 data
PremiumThe FlyWells upgrades Sutro to Overweight ahead of STRO-004 data
1M ago
Sutro Biopharma upgraded to Overweight from Equal Weight at Wells Fargo
Premium
The Fly
Sutro Biopharma upgraded to Overweight from Equal Weight at Wells Fargo
1M ago
Sutro Biopharma files $300M mixed securities shelf
Premium
The Fly
Sutro Biopharma files $300M mixed securities shelf
1M ago
Sutro Biopharma 7.87M share Secondary priced at $13.98
PremiumThe FlySutro Biopharma 7.87M share Secondary priced at $13.98
3M ago
Sutro Biopharma upgraded to Outperform from Market Perform at Citizens
Premium
The Fly
Sutro Biopharma upgraded to Outperform from Market Perform at Citizens
3M ago
Sutro Biopharma: Transition to STRO-004–Driven Clinical Execution Warrants Hold as Long-Term Upside Meets Near-Term Uncertainty
Premium
Ratings
Sutro Biopharma: Transition to STRO-004–Driven Clinical Execution Warrants Hold as Long-Term Upside Meets Near-Term Uncertainty
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100